04.04.13: Bonds: Bonds Issued
Bonds: Bonds IssuedNew: Bond Bayer Nordic SELink to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)
Source: Bayer IR Newsfeed: New on this site - April 12, 2013 Category: Pharmaceuticals Source Type: news

03.04.13: Events: Q1 2013 Conference Call
Events: Q1 2013 Conference CallOn the occasion of the publication of our First Quarter 2013 results we will host a conference call for investors and analysts on April 25, 2013 from approx. 2:00 p.m. CEST.Link to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)
Source: Bayer IR Newsfeed: New on this site - April 4, 2013 Category: Pharmaceuticals Source Type: news

25.03.13: Bonds: EMTN Program
Bonds: EMTN ProgramNew: Debt Issuance Programme Prospectus dated March 21, 2013Link to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)
Source: Bayer IR Newsfeed: New on this site - March 25, 2013 Category: Pharmaceuticals Source Type: news

18.03.13: Events: Meet Management 2013 LEV
Events: Meet Management 2013 LEVNew: Meet Management Investor Handout At approx. 9:00 a.m. CET (8:00 a.m. GMT): Live audio broadcast of the presentation given by Dr. Marijn Dekkers, CEO of Bayer AGLink to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)
Source: Bayer IR Newsfeed: New on this site - March 19, 2013 Category: Pharmaceuticals Source Type: news

13.03.13: Events: Meet Management 2013 LEV
Events: Meet Management 2013 LEVMeet Management 2013 in Leverkusen Tuesday, March 19, 2013 at approx. 9:00 a.m. CET (8:00 a.m. GMT): Live audio broadcast of the presentation given by Dr. Marijn Dekkers, CEO of Bayer AGLink to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)
Source: Bayer IR Newsfeed: New on this site - March 14, 2013 Category: Pharmaceuticals Source Type: news

28.02.13: Home: Home
Home: HomeNew: Q4 2012 Analyst and Investor Briefing Live Today: Financial News Conference at 10:00 a.m. CET Live Today: FY/Q4 2012 Investor Conference Call at 2:30 p.m. CETLink to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)
Source: Bayer IR Newsfeed: New on this site - February 28, 2013 Category: Pharmaceuticals Source Type: news

26.02.13: Stock: Dividends
Stock: DividendsBayer proposes dividend increase to EUR 1.90 per share for 2012.Link to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)
Source: Bayer IR Newsfeed: New on this site - February 26, 2013 Category: Pharmaceuticals Source Type: news

07.02.13: Events: FY/Q4 2012 Investor Conference Call
Events: FY/Q4 2012 Investor Conference CallInvestor Conference Call on February 28, 2013 on the occasion of the publication of Full Year and Fourth Quarter 2012 results.Link to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)
Source: Bayer IR Newsfeed: New on this site - February 7, 2013 Category: Pharmaceuticals Source Type: news

29.01.13: Stock: Consensus
Stock: ConsensusNew: Q4 2012 Consensus estimatesLink to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)
Source: Bayer IR Newsfeed: New on this site - January 29, 2013 Category: Pharmaceuticals Source Type: news

29.01.13: Stock: Analysts\' Ratings
Stock: Analysts\' RatingsUpdate Barclays: Downgrade to UnderweightLink to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)
Source: Bayer IR Newsfeed: New on this site - January 29, 2013 Category: Pharmaceuticals Source Type: news

15.01.13: Handouts: Investor Handout
Handouts: Investor HandoutUpdate: Q3 2012 Investor HandoutLink to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)
Source: Bayer IR Newsfeed: New on this site - January 16, 2013 Category: Pharmaceuticals Source Type: news

20.12.12: Bayer Group: Corporate Governance
Bayer Group: Corporate GovernanceNew: Declaration of Conformity 2012Link to websiteAll changes (Source: Bayer IR Newsfeed: New on this site)
Source: Bayer IR Newsfeed: New on this site - January 2, 2013 Category: Pharmaceuticals Source Type: news